Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.
To own IQVIA, you need to believe its AI-enabled clinical research and data platforms can keep winning work despite pricing pressure and rising competition. The latest results and raised 2026 revenue outlook support the near term growth catalyst around AI adoption and data-driven services, but uneven profit trends and high leverage keep margin execution and debt risk very much in focus. Overall, this quarter’s news does not materially change the core risk reward balance.
The most relevant recent announcement is IQVIA’s ongoing buyback activity, with 2,300,000 shares repurchased in the second quarter for US$395.17 million and authorization lifted to US$15.73 billion. Together with higher revenue guidance, this capital return program ties directly into the current catalyst of AI-led growth by signaling that management is willing to commit cash to shareholders while continuing to invest in data, analytics, and trial efficiency capabilities.
But despite stronger guidance, investors should still pay close attention to how high debt and leverage could limit flexibility if...
Read the full narrative on IQVIA Holdings (it's free!)
IQVIA Holdings' narrative projects $19.7 billion revenue and $2.0 billion earnings by 2029. This requires 5.7% yearly revenue growth and a roughly $0.6 billion earnings increase from $1.4 billion today.
Uncover how IQVIA Holdings' forecasts yield a $232.00 fair value, in line with its current price.
Some of the most cautious analysts were assuming only about 5.3% annual revenue growth to roughly US$19.4 billion by 2029 and tighter margins, painting a much more pessimistic picture than consensus and highlighting how differently you and others might assess IQVIA’s AI opportunity and balance sheet risks.
Explore 3 other fair value estimates on IQVIA Holdings - why the stock might be worth as much as 52% more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com